Literature DB >> 2406515

Trisomy 14 in atypical chronic myeloid leukemia.

F Mertens1, B Johansson, S Heim, U Kristoffersson, N Mandahl, I Turesson, C Malm, A Othzén, C R Bartram, D Catovsky.   

Abstract

Trisomy 14 was the sole karyotypic anomaly in three patients with Ph1-negative chronic myeloid leukemia, and the only abnormality in one of three clones in a fourth case. The hematologic features were partly myeloproliferative, partly myelodysplastic, and included myeloid hyperplasia, neutrophilia without basophilia, a relatively high number of immature granulocyte precursors in the peripheral blood, and monocytosis in three and dysgranulopoiesis in two of the patients. These data, in combination with the patients' high age at diagnosis, their short survival, and the lack of rearrangements of the major breakpoint cluster region (M-bcr) in the two cases where cells were available for molecular analysis, indicate that all four patients suffered from atypical chronic myeloid leukemia (aCML). We suggest that trisomy 14 may be a characteristic karyotypic abnormality in this hematologic disorder.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406515

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  5 in total

1.  Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome.

Authors:  E Montefusco; G Alimena; F Lo Coco; M R De Cuia; Y Z Wang; M A Aloe Spiriti; F Mancini; M Cedrone; M Mancini; F Mandelli
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

Review 2.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

3.  Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.

Authors:  Joseph Saliba; Cécile Saint-Martin; Antonio Di Stefano; Gaëlle Lenglet; Caroline Marty; Boris Keren; Florence Pasquier; Véronique Della Valle; Lise Secardin; Gwendoline Leroy; Emna Mahfoudhi; Sarah Grosjean; Nathalie Droin; M'boyba Diop; Philippe Dessen; Sabine Charrier; Alberta Palazzo; Jane Merlevede; Jean-Côme Meniane; Christine Delaunay-Darivon; Pascal Fuseau; Françoise Isnard; Nicole Casadevall; Eric Solary; Najet Debili; Olivier A Bernard; Hana Raslova; Albert Najman; William Vainchenker; Christine Bellanné-Chantelot; Isabelle Plo
Journal:  Nat Genet       Date:  2015-08-17       Impact factor: 38.330

4.  Further evidence for the molecular heterogeneity of chronic myeloid leukemia.

Authors:  A Hernandez; L Corral; A Muñiz; C Alaez; E Espinosa; G Martinez; P Hernandez
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

5.  Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia, and a wide spectrum of disease progression.

Authors:  Wei Cui; Carlos E Bueso-Ramos; C Cameron Yin; Jianlan Sun; Su Chen; Ramya Muddasani; Gary Lu
Journal:  J Biomed Biotechnol       Date:  2011-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.